Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health Ruchika Sharma26 April 2025 12:36 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the Committee...
Biosimilar Denosumab of Alkem (Denuril) shows Comparable Efficacy in Treating Postmenopausal Osteoporosis in Indian Women Deeksha Bhandari12 April 2025 12:19 PM ISTBiosimilar denosumab of Alkem (Denuril) showed comparable efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity to the innovator...
Aurobindo Pharma arm CuraTeQ Biologics completes successful Phase 1 Pharmacokinetics study of bone drug Ruchika Sharma10 April 2025 11:56 AM ISTDenosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the cells that break down bone.
Hyperbaric Oxygen Therapy and Conservative Approach Effectively Manage Severe MRONJ: Case Report Medha Baranwal9 April 2025 9:00 PM ISTJapan: Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication associated with the prolonged use of antiresorptive medications...
Study explores whether osteoporosis drug denosumab regenerate beta cells? Dr. Kamal Kant Kohli30 March 2025 11:30 AM ISTCity of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a top research center for...
Denosumab initiation for osteoporosis may decrease fracture risk but increase risk of CV events in dialysis patients: Study Dr. Kamal Kant Kohli7 Jan 2025 8:30 PM ISTResearchers have found in a observational study that dialysis patients on denosumab (Prolia, Xgeva) had a lower risk for fracture but higher risk for...
Denosumab Linked to Higher Risk of Severe Hypocalcemia in Older Female Dialysis-Dependent Patients: JAMA Medha Baranwal25 Nov 2024 8:00 PM ISTUSA: A target trial emulation study revealed that denosumab significantly increased the risk of hypocalcemia requiring emergency treatment compared to...
Revise protocol for Denosumab 60 mg prefilled syringe solution for injection: CDSCO Panel tells Lupin Susmita Roy23 Nov 2024 5:30 PM ISTNew Delhi: In line with the proposal presented by Lupin for conducting phase I study of Denosumab 60 mg prefilled syringe solution for injection (60...
Osteoporosis Medications Denosumab and Alendronate Have No Significant Effect on Vascular Calcification: SALTIRE2 Medha Baranwal18 Sept 2024 9:30 PM ISTUK: In a recent secondary analysis of the SALTIRE2 randomized controlled trial, researchers have found that commonly prescribed osteoporosis...
Alvotech, Dr Reddy's collaborate for commercialization of AVT03 in US, Europe and UK Ruchika Sharma23 May 2024 12:16 PM ISTHyderabad: Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
Denosumab Linked to High Incidence of Severe Hypocalcemia in Female Dialysis Patients 65 and Above: JAMA Aditi26 April 2024 10:00 PM ISTOsteoporosis, common in postmenopausal women, involves reduced bone density, fragile bones, and a higher fracture risk. Patients with advanced chronic...
Fat body Mass Tied to Vertebral Fractures in breast cancer patients on aromatase inhibitors and denosumab Dr Riya Dave29 Jan 2024 9:00 AM ISTA recent prospective cohort study sheds light on a previously unexplored aspect of bone health in postmenopausal women with early breast cancer (EBC)...
